The term Lynch-like syndrome (LLS) has been proposed for the patients who present with an MSI/dMMR tumor without MLH1 promoter hypermethylation when no pathogenic germline MMR gene variation is found. Here, MLH1 is linked to Luscan-Lumish syndrome.